Results 11 to 20 of about 8,991,947 (284)

ESSM Position Statement on Surgical Treatment of Peyronie's Disease [PDF]

open access: yesSexual Medicine, 2022
Introduction: Patients with Peyronie's disease may experience significat distress. The choice of treatment depends on a variety of factors, including the stage of the disease, the presence of pain, severity and direction of the curvature, penile length ...
Daniar Osmonov, MD, PhD, FECSM   +15 more
doaj   +3 more sources

An alternative non-invasive treatment for Peyronie's disease [PDF]

open access: diamondInternational Brazilian Journal of Urology, 2004
OBJECTIVE: Surgical correction of the deformity and plaque caused by Peyronie's disease has some important disadvantages and extracorporeal shockwave therapy (ESWT) emerged as a new promising therapy. We evaluated prospectively the efficacy and safety of
Joaquim A. Claro   +5 more
doaj   +2 more sources

Peyronie's disease questionnaire: translation into Danish and cultural adaptation. [PDF]

open access: yesSex Med, 2023
Background Peyronie’s disease has an impact on men’s mental and physical health. Aim We sought to translate the Peyronie’s Disease Questionnaire into Danish, adapt it to the Danish cultural setting, and test it in a Danish population. Methods Translation
Wiborg MH   +4 more
europepmc   +2 more sources

A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study [PDF]

open access: diamondInternational Brazilian Journal of Urology, 2016
Objectives: To compare the response to tiocolchicine and verapamil injection in the plaque of patients with Peyronie's disease. Materials and Methods: Prospective, single-blind, randomized study, selecting patients who have presented Peyronie's disease ...
I. L. Toscano Jr.   +5 more
doaj   +2 more sources

Bibliometric analysis of most cited Peyronie's disease and its management publications [PDF]

open access: yesFrontiers in Surgery
IntroductionPeyronie's disease (PD) is a common urologic illness, motivating numerous scientific investigations and publications. Scientific publications have more authors each year.
Mehmet Fatih Şahin   +5 more
doaj   +2 more sources

Fibroproliferative disorders and diabetes: Understanding the pathophysiologic relationship between Peyronie’s disease, Dupuytren disease and diabetes

open access: yesEndocrinology, Diabetes & Metabolism, 2021
Introduction Fibrosis is characterized by dysregulation and accumulation of extracellular matrix. Peyronie's disease and Dupuytren disease are fibroproliferative disorders of the tunica albuginea of the penis and fascia of the hand, respectively. Chronic
Martin K. Gelbard, Joel Rosenbloom
doaj   +2 more sources

Impact of extracorporeal shockwave therapy for erectile dysfunction and Peyronie's disease on reproductive and hormonal testicular function. [PDF]

open access: yesAndrology, 2022
Extracorporeal shock wave therapy is an established treatment for erectile dysfunction and Peyronie's disease. Concerns regarding the safety of extracorporeal shock wave therapy for andrological purposes on testicular function were raised by animal ...
Manfredi C   +12 more
europepmc   +2 more sources

Psychosexual Symptoms and Treatment of Peyronie's Disease Within a Collaborative Care Model [PDF]

open access: goldSexual Medicine, 2014
Introduction: Peyronie's disease (PD) can be emotionally and sexually debilitating for patients and may negatively impact partner relationships. Aims: This study aims to present an ongoing collaborative care model for patients with PD and to discuss the ...
Rose Hartzell, PhD, EdS, CHES, LMFT
doaj   +2 more sources

Peyronie's Disease: Evaluation and Review of Nonsurgical Therapy [PDF]

open access: goldThe Scientific World Journal, 2009
The purpose of our study was to outline the evaluation of the Peyronie's disease (PD) patient and review the available nonsurgical treatments. A review of the literature on oral, intralesional, external energy, iontophoresis, and mechanical therapies for
Michael R. Abern, Laurence A. Levine
doaj   +2 more sources

Inhibition of phosphodiesterases 1 and 4 prevents myofibroblast transformation in Peyronie's disease [PDF]

open access: yesBJU International, Volume 135, Issue 5, Page 810-817, May 2025.
Objectives To investigate which phosphodiesterase (PDE) isoforms are expressed in fibroblasts isolated from the tunica albuginea (TA) of patients with Peyronie's disease (PD), and to measure the potency of PDE inhibitors in preventing transformation of these fibroblasts to profibrotic myofibroblasts.
Sophie L. Harding   +4 more
wiley   +2 more sources

Home - About - Disclaimer - Privacy